LumiCyte, Inc. (LCI)

Focus:

Protein biochips, informatics, disease identification (in particular breast cancer, ovarian cancer, prostate cancer, diabetes)

Company Profile:

LCI was founded by T. William Hutchens in 1999 on research that was carried out at Baylor College of Medicine.

In August 2005 Qiagen entered a definitive agreement to acquire key assets of LCI.

Management:

John D. D. Kohler (CEO)

Address:

48480 Lakeview Boulevard
Fremont, CA 94538
USA
Phone: +1-510-226-3990
Fax: +1-510-226-4901

E-mail:

Website:

Technology:

LCI provides the STS Biochip™ platform for MALDI-MS for increased sensitivity, reproducibility and high throughput.

Information